As of 2024-12-15, the Relative Valuation of BioInvent International AB (BINV.ST) is (101.79) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 40.25 SEK, the upside of BioInvent International AB based on Relative Valuation is -352.9%.
The range of the Relative Valuation is (89.53) - (134.10) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 23.4x | 18.7x |
| Forward P/E multiples | 7.3x - 21.5x | 14.0x |
| Fair Price | (89.53) - (134.10) | (101.79) |
| Upside | -322.4% - -433.2% | -352.9% |
| Date | P/E |
| 2024-12-11 | -6.55 |
| 2024-12-10 | -6.67 |
| 2024-12-09 | -6.67 |
| 2024-12-06 | -7.04 |
| 2024-12-05 | -7.05 |
| 2024-12-04 | -7.00 |
| 2024-12-03 | -7.05 |
| 2024-12-02 | -7.02 |
| 2024-11-29 | -6.91 |
| 2024-11-28 | -7.10 |
| 2024-11-27 | -7.05 |
| 2024-11-26 | -7.16 |
| 2024-11-25 | -7.34 |
| 2024-11-22 | -7.16 |
| 2024-11-21 | -7.35 |
| 2024-11-20 | -7.33 |
| 2024-11-19 | -7.43 |
| 2024-11-18 | -7.63 |
| 2024-11-15 | -7.91 |
| 2024-11-14 | -8.16 |
| 2024-11-13 | -8.02 |
| 2024-11-12 | -7.65 |
| 2024-11-11 | -8.02 |
| 2024-11-08 | -7.81 |
| 2024-11-07 | -7.37 |
| 2024-11-06 | -7.23 |
| 2024-11-05 | -7.31 |
| 2024-11-04 | -6.99 |
| 2024-11-01 | -6.81 |
| 2024-10-31 | -6.95 |
| 2024-10-30 | -7.09 |
| 2024-10-29 | -7.44 |
| 2024-10-28 | -7.39 |
| 2024-10-25 | -7.03 |
| 2024-10-24 | -6.96 |
| 2024-10-23 | -6.95 |
| 2024-10-22 | -6.94 |
| 2024-10-21 | -6.95 |
| 2024-10-18 | -7.20 |
| 2024-10-17 | -7.10 |
| 2024-10-16 | -7.07 |
| 2024-10-15 | -6.99 |
| 2024-10-14 | -7.06 |
| 2024-10-11 | -7.05 |
| 2024-10-10 | -6.81 |
| 2024-10-09 | -6.94 |
| 2024-10-08 | -7.00 |
| 2024-10-07 | -7.11 |
| 2024-10-04 | -7.14 |
| 2024-10-03 | -7.22 |